Kerry A. Rogers, MD¹, Ying Huang, MS, MA^2*, Amy S. Ruppert, PhD², Lynne V. Abruzzo, MD, PhD³, Seema A Bhat, MD², Corinne Hoffman, MS, CNP^4*, Kami J. Maddocks, MD⁵, Gerard Lozanski, MD³, Adam S. Kittai, MD², Mollie E. Moran^4*, Mark Reid, CNP^4*, Jennifer A. Woyach, MD² and John C. Byrd, MD²

¹Division of Hematology, Ohio State University Hospital, Columbus, OH
²Division of Hematology, The Ohio State University, Columbus, OH
³Department of Pathology, The Ohio State University, Columbus, OH
⁴The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁵Division of Hematology, Department of Internal Medicine, Ohio State University Hospital, Columbus, OH

Jennifer R. Brown, MD, PhD^1*, Tadeusz Robak, MD PhD², Paolo Ghia, MD, PhD³, Brad S. Kahl, MD⁴, Patricia Walker, MBBS, BMedSci, FRACP, FRCPA^5*, Wojciech Janowski, MBChB, FRCPA, FRACP^6*, Henry Chan, MBChB, FRACP, FRCPA⁷, Mazyar Shadman, MD, MPH^8,9*, Peter S. Ganly, BMBCh, PhD^10,11, Luca Laurenti, MD^12*, Stephen Opat, MBBS (Hons), FRACP, FRCPA^13,14, Monica Tani, MD^15*, Hanna Ciepluch, MD^16*, Emma Verner, MBBS, BMedSci, FRCPA, FRACP^17*, Martin Šimkovič, MD, PhD^18,19*, Anders Österborg, MD, PhD^20,21, Marek Trněný, MD²², Alessandra Tedeschi, MD^23*, Piers Blombery, MBBS^24*, Jason C. Paik, MD, PhD^25*, Fangfang Yin, PhD^25*, Shibao Feng, PhD^25*, Vanitha Ramakrishnan, PhD^25*, Jane Huang, MD^25*, Peter Hillmen, MBChB, PhD, FRCP, FRCPath²⁶ and Constantine S. Tam, MBBS, MD^24,27,28,29*

¹Dana-Farber Cancer Institute, Boston, MA
²Medical University of Lodz, Lodz, Poland
³Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy
⁴Washington University School of Medicine in St. Louis, Saint Louis, MO
⁵Peninsula Private Hospital, Frankston, VIC, Australia
⁶Calvary Mater Newcastle, Waratah, NSW, Australia
⁷North Shore Hospital, Auckland, New Zealand
⁸Department of Medicine, University of Washington, Seattle, WA
⁹Fred Hutchinson Cancer Research Center, Seattle, WA
¹⁰Department of Haematology, Christchurch Hospital, Christchurch, New Zealand
¹¹Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand
¹²Fondazione Policlinico Universitario A Gemelli UCSC, Roma, Italy
¹³Monash Health, Clayton, VIC, Australia
¹⁴Monash University, Clayton, VIC, Australia
¹⁵Haematology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy
¹⁶Department of Hematology, Copernicus Regional Oncology Centre, Gdansk, Poland
¹⁷Concord Repatriation General Hospital, Concord, NSW, Australia
¹⁸4th Department of Internal Medicine - Hematology, University Hospital, Hradec Kralove, Czech Republic
¹⁹Faculty of Medicine, Charles University, Prague, Czech Republic
²⁰Department of Hematology, Karolinska University Hospital, Stockholm, Sweden
²¹Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden
²²First Department of Medicine, First Faculty of Medicine, Charles University, General Hospital, Prague, Czech Republic
²³ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
²⁴Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
²⁵BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, CA
²⁶St. James's University Hospital, Leeds, United Kingdom
²⁷Royal Melbourne Hospital, Parkville, VIC, Australia
²⁸St. Vincent's Hospital, Fitzroy, VIC, Australia
²⁹University of Melbourne, Parkville, VIC, Australia

Jacob D. Soumerai, MD¹, Anthony R. Mato, MD², Jason Carter, MPH, PA-C^2*, Ahmet Dogan, MD, PhD³, Ephraim P Hochberg, MD^4*, Jeffrey A Barnes, MD, PhD⁴, Audrey Hamilton, MD^5*, Jeremy S Abramson, MD, MMSc⁴, Connie Lee Batlevi, MD, PhD², Erel Joffe, MD, MSc⁵, Matthew J Matasar, MD, MS⁶, Ariela Noy, MD², Colette Owens, MD⁵, M. Lia Palomba, MD², Tak Takvorian, MD^4*, Venkatraman Seshan, PhD^7*, Kelsey Flaherty^2*, Lauren Ramos^4*, Morgan Choma^2*, Chaya Friedman^2*, Puja Chadha^2*, Elizabeth Simkins^4*, Daneal Portman^4*, Neena Majahan, NP^2*, Rosalba Martignetti, RN^4*, Joanna Mi, NP^2*, Krista J Scorsune, NP^4*, Julia M Lynch, NP^4*, Brianne McGree, NP^4*, Stephanie Y Hughes^2*, Clare Grieve^2*, Lindsey E Roeker, MD², Omar Abdel-Wahab, MD ² and Andrew D Zelenetz, MD, PhD⁵

¹Massachusetts General Hospital, Boston, MA
²Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Massachusetts General Hospital Cancer Center, Boston, MA
⁵Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Department of Medicine, Lymphoma Service, Memorial Sloan-Kettering Cancer Center/New York Presbyterian, New York, NY
⁷Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY

Benjamin Heyman, MD¹, Michael Y. Choi, MD², Emanuela M. Ghia, PhD³, George F. Widhopf II, PhD⁴, Minya Pu, PhD^4*, Emily Pittman, PhD^4*, Karen Messer, PhD^5*, Catriona Jamieson, MD, PhD⁶ and Thomas J. Kipps, MD, PhD⁴

¹Moores Cancer Center and Sanford Consortium for Regenerative Medicine, UC San Diego Health, La Jolla, CA
²University of California-San Diego, San Diego, CA
³Moores Cancer Center, University of California, San Diego, San Diego, CA
⁴Moores Cancer Center, University of California, San Diego, La Jolla, CA
⁵Ucsd, La Jolla, CA
⁶CIRM Alpha Stem Cell Clinic, University California, San Diego, La Jolla, CA

Kerry A. Rogers, MD¹, Ian W. Flinn, MD, PhD², Carolyn McGarry, PhD^3*, Liangke Connie Gou, PhD^3*, Nadia Hassounah, PhD^4*, Janghee Woo, MD^4* and John C. Byrd, MD¹

¹Division of Hematology and Ohio State University Comprehensive Cancer Center, Columbus, OH
²Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN
³Novartis Pharmaceuticals Corporation, East Hanover, NJ
⁴Novartis Institutes for BioMedical Research, Cambridge, MA

Othman Al-Sawaf, MD^1*, Can Zhang, PhD^2*, Maneesh Tandon, MD^3*, Sandra Robrecht, PhD^1*, Arijit Sinha, PhD^4*, Anna-Maria Fink, MD^5*, William Schary, PhD⁶, Clemens-Martin Wendtner^7*, Barbara Eichhorst, MD⁸, Michele Porro Lura^9*, Michael Hallek¹⁰ and Kirsten Fischer, MD^2*

¹Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne, Germany
²Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German CLL Study Group, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany, Cologne, Germany
³Roche Products Limited, Welwyn Garden City, United Kingdom
⁴F. Hoffmann-La Roche Ltd, Basel, Switzerland
⁵University Hospital Cologne, Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf; Cologne, Cologne, Germany
⁶AbbVie, North Chicago, IL
⁷Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilians-University, Munich, Germany
⁸Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, University of Cologne, Cologne, Germany
⁹F. Hoffmann-La Roche Ltd., Basel, Switzerland
¹⁰Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf and German CLL Study Group, University of Cologne, Cologne, Germany

Meghan C. Thompson, MD¹, Matthew S. Davids, MD², Nitin Jain, MD³, Jacob D. Soumerai, MD⁴, Praveen Ramakrishnan Geethakumari, MD, MS⁵, Amy Gubits, MPH^6*, Denice Kaylor Hickman, BSN, RN^6*, Anders Wennborg, MD, PhD^7*, Eyal C. Attar, MD⁶, Omar Abdel-Wahab, MD ¹ and Anthony R. Mato, MD¹

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Dana-Farber Cancer Institute, Boston, MA
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Massachusetts General Hospital, Boston, MA
⁵University of Texas Southwestern Medical Center, Dallas, TX
⁶Aprea Therapeutics, Boston, MA
⁷Aprea Therapeutics, Solna, SWE

Jennifer A. Woyach, MD¹, James S. Blachly, MD¹, Kerry A. Rogers, MD¹, Seema A Bhat, MD¹, Michael R. Grever, MD¹, Adam S. Kittai, MD¹, Mojgan Jianfar, MD^1*, Gerard Lozanski, MD¹, David M. Weiss^1*, Barbara L. Andersen, PhD^1*, Priti Patel, MD², Veerendra Munugalavadla, PhD², Anna Butturini, MD², Yan Xu^2*, Min Hui Wang, PhD^2* and John C. Byrd, MD¹

¹The Ohio State University Comprehensive Cancer Center, Columbus, OH
²Acerta Pharma, South San Francisco, CA

Othman Al-Sawaf, MD^1*, Can Zhang, PhD^2*, Sandra Robrecht, PhD^3*, Anna-Maria Fink, MD^4*, Paula Cramer^5*, Carmen D. Herling, MD, PhD^6*, Julia Von Tresckow, MD^7*, Elisabeth Lange, MD^8*, Sebastian Böttcher, MD, PhD^9*, Michael G. Kiehl, MD, PhD¹⁰, Martin Dreyling, MD¹¹, Ulrich Jaeger, MD¹², Michael Gregor, MD^13*, Ursula Vehling-Kaiser, MD^14*, Matthias Ritgen, MD^15*, Jan Dürig, MD^16*, Eugen Tausch, MD^17*, Stephan Stilgenbauer, MD^17,18, Clemens-Martin Wendtner, MD¹⁹, Kirsten Fischer, MD^3*, Valentin Goede, MD,^20*, Michael Hallek, MD^3*, Barbara Eichhorst, MD³ and Petra Langerbeins, MD^21*

¹University of Cologne, Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, Cologne, Cologne, Germany
²Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital, Cologne, Cologne, Germany
³Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, University of Cologne, Cologne, Germany
⁴University Hospital Cologne, Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf; Cologne, Cologne, Germany
⁵Department of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf; Cologne, University of Cologne, Cologne, Germany
⁶Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German CLL Study Group, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany, Cologne, Germany
⁷Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf; Cologne, University of Cologne, Koeln, Germany
⁸Department of Hematology and Oncology, Evangelisches Krankenhaus Hamm, Hamm, Germany
⁹Department of Internal Medicine II, Kiel, DEU
¹⁰Department of Internal Medicine, Klinikum Frankfurt (Oder) GmbH, Frankfurt, Germany
¹¹Department of Internal Medicine III, University Hospital of the Ludwig Maximilians University Munich, Munich, Germany
¹²Department of Internal Medicine I, Medical University of Vienna, Vienna, AA, Austria
¹³Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland
¹⁴Hematology Oncology, Dayclinic Landshut, Landshut, Germany
¹⁵Department of Internal Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany
¹⁶Department of Hematology, Essen University Hospital, Essen, Germany
¹⁷Department of Internal Medicine III, University Hospital Ulm, Ulm, Ulm, Germany
¹⁸Department of Internal Medicine I, Saarland University Medical School, Homburg, Germany
¹⁹Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine, German CLL Study Group, Munich Clinic Schwabing, Munich, Germany
²⁰Oncogeriatric Unit, Department of Geriatric Medicine, St. Marien Hospital, Cologne, Germany
²¹Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf; Cologne, University of Cologne, Cologne, Germany

James S. Blachly, MD¹, Nicole Lamanna, MD², Deborah M. Stephens, DO³, J Christine Ye, MD, MSc⁴, Michael Niesman, PhD^5*, Kai Zhang, MD^5* and Jennifer A. Woyach, MD¹

¹Division of Hematology, The Ohio State University, Columbus, OH
²Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY
³University of Utah/Huntsman Cancer Institute, Salt Lake City, UT
⁴University of Michigan, Ann Arbor, MI
⁵MingSight Pharmaceuticals, Inc., San Diego, CA

Oliver Cornely, MD^1*, Anthony Mato, MD^2*, Tadeusz Robak, MD PhD³, Sibylle Mellinghoff, MD^1* and Tatiana Lavrova, MD^4*

¹CECAD Cluster of Excellence & Dep of Internal Medicine, University Hospital of Cologne, Cologne, Germany
²Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland
⁴Octapharma Pharm.Prod.ges.m.b.H., Vienna, Austria

Paula Cramer^1*, Julia Von Tresckow, MD^2,3*, Anna-Maria Fink, MD^2*, Gracia Braun^2*, Sandra Robrecht, PhD^2*, Can Zhang, PhD^2*, Eugen Tausch, MD^4*, Lothar Müller, MD^5*, Wolfgang Knauf, MD⁶, Othman Al-Sawaf, MD^2*, Benedikt Pelzer, MD^2*, Petra Langerbeins, MD^2*, Kirsten Fischer, MD^2*, Karl-Anton Kreuzer, MD^2*, Matthias Ritgen, MD^7*, Michael Kneba, MD, PhD⁷, Clemens-Martin Wendtner, MD⁸, Stephan Stilgenbauer, MD⁴, Barbara Eichhorst, MD² and Michael Hallek, MD^2*

¹Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital, Cologne, Cologne-Bonn, Germany
²Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital, Cologne, Cologne, Germany
³Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Essen, Germany
⁴Department of Internal Medicine III, University Hospital Ulm, Ulm, Ulm, Germany
⁵Practice for Hematology and Oncology UnterEms, Leer, Leer, Germany
⁶Practice for Hematology and Oncology Bethanien, Frankfurt/Main, Frankfurt/Main, Germany
⁷Department of Internal Medicine II, Campus Kiel, University of Schleswig-Holstein, Kiel, Kiel, Germany
⁸Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine, Klinikum Schwabing, Munich, Munich, Germany

Talal Hilal, MD¹, William B Hillegass, MD, PhD^2*, Miguel Gonzalez-Velez, MD^3*, Jose F. Leis, MD, PhD⁴ and Allison C. Rosenthal, D.O.⁵

¹Division of Hematology/Oncology, University of Mississippi Medical Center, Jackson, MS
²Department of Medicine and Data Science, University of Mississippi Medical Center, Jackson, MS
³Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
⁴Division of Hematology and Medical Oncology, Mayo Clinic Health System, Phoenix, AZ
⁵Mayo Clinic, Phoenix, AZ

Constantine S. Tam, MBBS, MD^1,2,3,4, Ian W. Flinn, MD, PhD⁵, Alessandra Tedeschi, MD^6*, Emmanuelle Ferrant, MD^7*, Jennifer R. Brown, MD, PhD^8*, Tadeusz Robak, MD PhD⁹, Paolo Ghia, MD, PhD¹⁰, Sowmya B. Kuwahara, PharmD^11*, Jason C. Paik, MD, PhD^11*, Lei Hua, PhD^11*, Aileen Cohen, MD, PhD^11*, Jane Huang, MD^11* and Peter Hillmen, MBChB, PhD, FRCP, FRCPath¹²

¹St Vincent's Hospital, Fitzroy, VIC, Australia
²Royal Melbourne Hospital, Parkville, VIC, Australia
³University of Melbourne, Melbourne, VIC, Australia
⁴Peter MacCallum Cancer Centre, Parkville, VIC, Australia
⁵Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
⁶ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
⁷Centre Hospitalier Lyon-Sud, University Claude Bernard Lyon 1, Pierre-Bénite, France
⁸Dana-Farber Cancer Institute, Boston, MA
⁹Medical University of Lodz, Lodz, Poland
¹⁰Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milano, MI, Italy
¹¹BeiGene (Beijing) Co., Ltd., Beijing, China and BeiGene USA, Inc., San Mateo, CA
¹²St. James's University Hospital, Leeds, United Kingdom

Anna Maria Frustaci^1*, Annalisa Biagi, MD^2*, Annalisa Chiarenza, MD, PhD^3*, Marta Coscia, MD, PhD^4*, Stefania Ciolli⁵, Luca Laurenti, MD^6*, Paolo Sportoletti, MD^7*, Gianluigi Reda, MD^8*, Marzia Varettoni^9*, Francesca Romana Mauro, MD^10*, Roberta Murru, MD^11*, Claudia Baratè, MD^12*, Antonino Greco, MD^13*, Chiara Borella, MD^14*, Giulia Zamprogna, MD^1*, Enrica Antonia Martino, MD^3*, Candida Vitale, MD, PhD^4*, Francesca Morelli, MD^5*, Alberto Fresa, MD^6*, Valerio Guarente, MD^7*, Alessandro Noto, MD^8*, Massimiliano Postorino, MD^2*, Roberto Cairoli, MD^1*, Marco Montillo¹, Giovanni Del Poeta, MD² and Alessandra Tedeschi, MD^1*

¹Department of Haematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
²Hematology, Department of Biomedicine and Prevention, University Tor Vergata, Roma, Italy
³Division of Hematology, A.O.U. "Policlinico-Vittorio Emanuele", University of Catania, Catania, Italy
⁴Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Turin, Torino, Italy
⁵Department of Hematology, Università degli Studi di Firenze, Firenze, Italy
⁶Hematology Institute, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Roma, Italy
⁷Department of Medicine, Division of Hematology and Clinical Immunology, University of Perugia, Perugia, Italy
⁸Hematology Department, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy
⁹Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
¹⁰Hematology, Department of Translational and Precision Medicine, Sapienza University, Policlinico Umberto I, Roma, Italy
¹¹Haematology and Stem Cell Transplantation Unit, Ospedale A. Businco, Cagliari, CAGLIARI, Italy
¹²Department of Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa, Italy
¹³Division of Hematology, Azienda Ospedaliera Giovanni Panìco, Tricase, Italy
¹⁴Division of Haematology, Ospedale San Gerardo, Monza, Italy

Wei Xu, MD, PhD¹, Yongping Song, MD^2*, Tingyu Wang^3*, Shenmiao Yang^4*, Lihong Liu, MD^5*, Yu Hu, MD^6*, Wei Zhang^7*, Jianfeng Zhou, MD, PhD^8*, Sujun Gao^9*, Kaiyang Ding^10*, Huilai Zhang, MD, PhD^11*, Zunmin Zhu, MD^12*, Shun-Qing Wang^13*, Bing Xu, MD, PhD^14*, Jianda Hu^15*, Ting Liu, MD, PhD¹⁶, Chunyan Ji, MD^17*, Zhongjun Xia, MD, PhD¹⁸, Yan Li, PhD, MD^19*, Xin Wang, MD, PhD²⁰, Huaqiang Zhu, MD^21*, Renbin Zhao, PhD^21*, Bin Zhang, PhD^21*, Zhixin Xu, MD, PhD^21* and Jianyong Li, MD, PhD¹

¹Department of Hematology, Pukou CLL Center, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
²Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan Province, China
³National Clinical Research Center for Blood Diseases, State Key Laboratory of Experimental Hematology, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁴Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing, CHN
⁵The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
⁶Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁷Peking Union Medical College Hospital, Beijing, Beijing, CHN
⁸Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁹Jilin University First Hospital, Changchun, China
¹⁰The First Affiliated Hospital of University of Science and Technology of China, Hefei, China
¹¹Department of Lymphoma, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
¹²Hematology, Henan Provincial People's Hospital, Zhengzhou, CHN
¹³Guangzhou First People's Hospital, Guangzhou, CHN
¹⁴Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China
¹⁵Department of Hematology, Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fuzhou, Fu, CHN
¹⁶Department of Hematology, West China Hospital of Sichuan University, Chengdu, China
¹⁷Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China
¹⁸Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
¹⁹Department of Hematology, The First Affiliated Hospital of China Medical University, Shenyang City, China
²⁰Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China
²¹Beijing InnoCare Pharma Tech Co., Ltd, Beijing, China

Jade Jones, MD¹, Binsah Susan George, MD^2*, Christine B Peterson^3*, Thao-Mi Tran Ha^4*, Jan A. Burger, MD, PhD⁵, Nitin Jain, MD⁶, Michael J. Keating, MBBS⁷, William G. Wierda, MD, PhD⁸, Jean-Bernard Durand, MD^9* and Alessandra Ferrajoli, MD^5,7,10,11,12

¹Vanderbilt University Medical Center, Houston, TX
²Vandersbilt University Medical Center, Nashville, TN
³Department of Biostatistics, UT MD Anderson Cancer Center, Houston
⁴University of Texas Austin, Austin, TX
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Associate Professor of Medicine Department of Leukemia The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁸Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Cardiology, Division of Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
¹²Leukemia department, The University of Texas MD Anderson Cancer Center, Houston, TX